Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment

被引:126
作者
Palepu, A
Horton, NJ
Tibbetts, N
Meli, S
Samet, JH
机构
[1] Univ British Columbia, St Pauls Hosp, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V5Z 1M9, Canada
[2] DM STAT Inc, Medford, MA USA
[3] Boston Univ, Sch Med, Northampton, MA USA
[4] Boston Univ, Sch Publ Hlth, Northampton, MA USA
[5] Smith Coll, Dept Math, Northampton, MA 01063 USA
[6] Boston Univ, Dept Med, Gen Internal Med Sect, CARE Unit, Vancouver, WA USA
[7] Boston Univ, Dept Social & Behav Sci, Vancouver, WA USA
关键词
access; adherence; alcohol; antiretroviral therapy; HIV; substance abuse treatment; substance use;
D O I
10.1111/j.1360-0443.2003.00670.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aim We examined the association of substance abuse treatment with uptake, adherence and virological response to highly active antiretroviral therapy (HAART) among HIV-infected people with a history of alcohol problems. Design Prospective cohort study. Methods A standardized questionnaire was administered to 349 HIV-infected participants with a history of alcohol problems regarding demographics, substance use, use of substance abuse treatment and uptake of and adherence to HAART. These subjects were followed every 6 months for up to seven occasions. We defined substance abuse treatment services as any of the following in the past 6 months: 12 weeks in a half-way house or residential facility; 12 visits to a substance abuse counselor or mental health professional; or participation in any methadone maintenance program. Our outcome variables were uptake of antiretroviral therapy, 30-day self-reported adherence and HIV viral load suppression. Findings At baseline, 59% (205/349) of subjects were receiving HAART. Engagement in substance abuse treatment was independently associated with receiving antiretroviral therapy (adjusted OR; 95% CI: 1.70; 1.03-2.83). Substance abuse treatment was not associated with 30-day adherence or HIV viral load suppression. More depressive symptoms (0.48; 0.32-0.78) and use of drugs or alcohol in the previous 30 days (0.17; 0.11-0.28) were associated with worse 30-day adherence. HIV viral load suppression was positively associated with higher doses of antiretroviral medication (1.29; 1.15-1.45) and older age (1.04; 1.00-1.07) and negatively associated with use of drugs or alcohol in the previous 30 days (0.51; 0.33-0.78). Conclusion Substance abuse treatment was associated with receipt of HAART; however, it was not associated with adherence or HIV viral load suppression. Substance abuse treatment programs may provide an opportunity for HIV-infected people with alcohol or drug problems to openly address issues of HIV care including enhancing adherence to HAART.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 50 条
[1]   Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature [J].
Ammassari, A ;
Trotta, MP ;
Murri, R ;
Castelli, F ;
Narciso, P ;
Noto, P ;
Vecchiet, J ;
D'Arminio Monforte, A ;
Wu, AW ;
Antinori, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S123-S127
[2]   SCREENING FOR DEPRESSION IN WELL OLDER ADULTS - EVALUATION OF A SHORT-FORM OF THE CES-D [J].
ANDRESEN, EM ;
MALMGREN, JA ;
CARTER, WB ;
PATRICK, DL .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1994, 10 (02) :77-84
[3]   Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring [J].
Arnsten, JH ;
Demas, PA ;
Farzadegan, H ;
Grant, RW ;
Gourevitch, MN ;
Chang, CJ ;
Buono, D ;
Eckholdt, H ;
Howard, AA ;
Schoenbaum, EE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1417-1423
[4]   Helping the urban poor stay with antiretroviral HIV drug therapy [J].
Bamberger, JD ;
Unick, J ;
Klein, P ;
Fraser, M ;
Chesney, M ;
Katz, MH .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (05) :699-701
[5]   Protease inhibitors in the homeless [J].
Bangsberg, D ;
Tulsky, JP ;
Hecht, FM ;
Moss, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (01) :63-65
[6]   Addressing the challenges of adherence [J].
Bartlett, JA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 :S2-S10
[7]  
Bassetti S, 1999, J ACQ IMMUN DEF SYND, V21, P114
[8]   Changing patient characteristics with increased methadone maintenance availability [J].
Brands, B ;
Blake, J ;
Marsh, D .
DRUG AND ALCOHOL DEPENDENCE, 2002, 66 (01) :11-20
[9]   SCREENING FOR ALCOHOL-ABUSE USING CAGE SCORES AND LIKELIHOOD RATIOS [J].
BUCHSBAUM, DG ;
BUCHANAN, RG ;
CENTOR, RM ;
SCHNOLL, SH ;
LAWTON, MJ .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :774-777
[10]   Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].
Carpenter, CCJ ;
Cooper, DA ;
Fischl, MA ;
Gatell, JM ;
Gazzard, BG ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schechter, M ;
Schooley, RT ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390